GLP-1, TZD Combo May Cut Heart Risk (CME/CE)
(MedPage Today) -- The GLP-1 agonist exenatide (Byetta, Bydureon) may temper the cardiovascular risks associated with rosigltiazone (Avandia), possibly via its effects on a clotting pathway, a database study suggests. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 9, 2013 Category: Cardiology Source Type: news

Byetta Lawsuit News: Bernstein Liebhard LLP Notes Establishment of...
Byetta lawsuits pending in the new multidistrict litigation allege the drug’s makers failed to warn of a possible connection between Byetta and pancreatic cancer.(PRWeb August 27, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11065921.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 28, 2013 Category: Pharmaceuticals Source Type: news

Byetta May Help in Type 1 Diabetes, Too (CME/CE)
(MedPage Today) -- The GLP-1 agonist exenatide (Byetta) used in type 2 diabetes may have metabolic effects on patients with type 1 disease, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 14, 2013 Category: Cardiology Source Type: news

Byetta Lawsuit Investigation Being Conducted by Bernstein Liebhard LLP...
Dozens of Byetta lawsuits now pending in federal court allege the drug’s makers failed to warn of a possible connection between Byetta and pancreatic cancer, pancreatitis and thyroid cancer.(PRWeb August 10, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11015808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 11, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuit - Claims Move Forward, as Panel Considers Consolidation...
The Firm is investigating alleged Byetta pancreatic cancer lawsuits, as well as claims involving Byetta and pancreatitis and thyroid cancer.(PRWeb July 26, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10969663.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 27, 2013 Category: Pharmaceuticals Source Type: news

Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Former Eli Lilly executive brings wealth of diabetes insights, business strategy and global pharma leadership experience to Intarcia during critical time of opportunity BOSTON, July 26, 2013 -- (Healthcare Sales & Marketing Network) -- Intarcia Therape... Biopharmaceuticals, Drug Delivery, PersonnelIntarcia Therapeutics, ITCA 650, exenatide (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuit News: Bernstein Liebhard LLP Awaits Decision on...
The Firm is investigating Byetta lawsuits on behalf of individuals treated with the type 2 diabetes drug who went on to develop pancreatic cancer, pancreatitis and thyroid cancer.(PRWeb July 20, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10948003.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 22, 2013 Category: Pharmaceuticals Source Type: news

Byetta Pancreatic Cancer Lawsuits: Bernstein Liebhard LLP Comments on...
The Firm is investigating Byetta lawsuits on behalf of individuals treated with the type 2 diabetes drug who went on to develop pancreatic cancer, pancreatitis and thyroid cancer.(PRWeb July 13, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10925201.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 13, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuits Move Forward, as Judicial Panel Considers...
The Firm is investigating lawsuits on behalf of alleged victims of Byetta pancreatitis, Byetta pancreatic cancer, or Byetta thyroid cancer.(PRWeb July 08, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10906203.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 9, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuit Website Launched by Bernstein Liebhard LLP Provides...
The Firm is currently investigating Byetta lawsuit claims on behalf of patients who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer after taking the type 2 diabetes medication.(PRWeb June 28, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10884421.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 30, 2013 Category: Pharmaceuticals Source Type: news

The therapeutic virtues of venom
This article appeared in Guardian Weekly, which incorporates material from Le MondeMedical researchBiochemistry and molecular biologyZoologyPharmaceuticals industryWildlifeVahé Ter Minassianguardian.co.uk © 2013 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms & Conditions | More Feeds     (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 21, 2013 Category: Science Authors: Vahé Ter Minassian Tags: Pharmaceuticals industry Medical research Features Guardian Weekly Zoology Environment Biochemistry and molecular biology Business Science Wildlife Source Type: news

Byetta Lawsuit News: Bernstein Liebhard LLP Comments on American...
The Firm is investigating Byetta lawsuits on behalf of individuals who developed pancreatitis, pancreatic cancer, or thyroid cancer while using this medication.(PRWeb June 19, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10849904.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 21, 2013 Category: Pharmaceuticals Source Type: news

Byetta Pancreatic Cancer Lawsuit News: Bernstein Liebhard LLP Comments...
The Firm is investigating Byetta lawsuits on behalf of type 2 diabetics who developed pancreatic cancer, pancreatitis, or thyroid cancer, allegedly due to Byetta.(PRWeb June 20, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10854869.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 21, 2013 Category: Pharmaceuticals Source Type: news

Bernstein Liebhard LLP Investigating Diabetes Drug Lawsuits Involving...
The Firm is investigating diabetes drug lawsuits on behalf of patients who took Byetta, Januvia, Victoza or similar medications and were diagnosed with pancreatitis, pancreatic cancer or thyroid...(PRWeb June 16, 2013)Read the full story at http://www.prweb.com/releases/diabetes-drug-lawsuit/pancreatic-cancer/prweb10837515.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 16, 2013 Category: Pharmaceuticals Source Type: news

Diabetes drugs may be linked to pancreatic cancer
Conclusion This article presents important concerns that glucagon-like peptide-1 (GLP-1) agonists and dipeptidylpeptidase-4 (DPP-4) inhibitors could potentially increase the risk of inflammation and cancerous changes in the pancreas. The agencies that regulate medicines in Europe and the USA are aware of these issues, and told the BMJ that their analyses show increased reporting of pancreatic cancer among people taking these types of drugs. However, the agencies note that it has not been established whether these drugs directly cause the adverse effects seen in the pancreas. Both agencies are reviewing emerging eviden...
Source: NHS News Feed - June 10, 2013 Category: Consumer Health News Tags: Medication Diabetes QA articles Source Type: news